-
Bharat Biotech ships out COVAXIN to 11 cities
expresspharma
January 14, 2021
It has received a government purchase order for 55 lakh doses, the company has also donated 16.5 lakh doses to the Government of India.
-
Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline
pharmaceutical-business-review
January 12, 2021
Clinical-stage biopharmaceutical company Affinivax has secured $226m in Series C financing to advance the development of new vaccines with its multiple antigen presenting system (MAPS) platform.
-
Merck acquires Germany-based CDMO, AmpTec
expresspharma
January 08, 2021
The acquisition to expand Merck’s lipid manufacturing expertise and mRNA capabilities for vaccines, treatments and diagnostics.
-
US may halve doses of Moderna vaccine to speed rollout: Moncef Slaoui
expresspharma
January 05, 2021
Moncef Slaoui, Head of Operation Warp Speed, said that officials were in talks with Moderna and the Food and Drug Administration about the idea.
-
Dry run for COVID-19 vaccine roll out in all States/UTs on January 2, 2021
expresspharma
January 04, 2021
The activity is proposed to be conducted in all state capitals in at least three session sites; Maharashtra and Kerala are likely to schedule the dry run in major cities other than their capital.
-
HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine
expresspharma
January 04, 2021
The Hindustan Syringes and Medical Devices (HMD) receives the WHO- Performance, Quality and Safety (PQS) certification for its 0.3 ml Kojak AD Syringes, which are mainly required for the Pfizer’s Corona vaccine.
-
Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate
prnasia
December 31, 2020
Eurocine Vaccines AB has today selected Biovian Oy, Turku, Finland, as the contract developer for the Company's vaccine candidate against chlamydia. Biovian, which is an internationally recognized contract developer and manufacturer with its own GMP ...
-
Serum Institute of India launches indigenously developed pneumococcal vaccine, ‘PNEUMOSIL’
expresspharma
December 29, 2020
This WHO pre-qualified PCV is specially tailored to the prevailing serotype prevalence of S. pneumoniae in India and other regions of the world.
-
US vaccine rollout’s next challenge: Verifying who is ‘essential’
expresspharma
December 24, 2020
The vaccination campaign under way is now focused on hospital staff and nursing homes, tightly controlled environments.
-
India likely to approve AstraZeneca vaccine by next week – sources
expresspharma
December 23, 2020
AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates.